Marty Makary resigns as FDA commissioner following industry and White House backlash

by | May 12, 2026 | Uncategorized

Spread the love
Makary’s tenure was marked by internal dysfunction at the FDA, leadership turmoil and mounting backlash from drugmakers and physicians on regulatory decisions.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments